AJ Bergmann | CFO |
Linda Marban | CEO |
Joe Pantginis | H.C. Wainwright |
Good afternoon, ladies and gentlemen and welcome to the Capricor Therapeutics Second Quarter 2023 Financial Results and Corporate Update Call. At this time all lines are in a listen-only mode.
Following the presentation we’ll conduct a question-and-answer session. [Operator Instructions] As a reminder, this conference call is being recorded.
I would now like to turn the conference over to our host, Mr.